MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-12-2026
Synlogic Total Shareholders Equity 2011-2026 | SYBX
Annual Total Shareholders Equity Synlogic
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11.9 M | 12.8 M | 32.8 M | 82.6 M | 147 M | 115 M | 157 M | 124 M | 85 M | 8.5 M | 85 M | -48 M | -29.9 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 157 M | -48 M | 60.3 M |
Quarterly Total Shareholders Equity Synlogic
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.3 M | 12.6 M | 13.1 M | 12.8 M | 13.1 M | 13.1 M | 9.4 M | 32.8 M | 43.4 M | 54.8 M | 68.7 M | 82.6 M | 100 M | 117 M | 132 M | 147 M | 162 M | 128 M | 109 M | 115 M | 115 M | 115 M | 115 M | 157 M | 157 M | 157 M | 157 M | 124 M | 124 M | 124 M | 124 M | 85 M | 85 M | 85 M | 85 M | 8.5 M | 8.5 M | 60.4 M | 60.4 M | 977 K | 85 M | 85 M | 85 M | -48 M | -48 M | - | - | -29.9 M | - | - | - | -24.4 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 162 M | -48 M | 73 M |
Total Shareholders Equity of other stocks in the Biotechnology industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
621 M | - | 2.43 % | $ 254 M |  Germany |
 |
Advaxis
ADXS
|
-24.4 M | - | -9.65 % | $ 45.9 M |  USA |
 |
Akouos
AKUS
|
234 M | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
169 M | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
78.8 M | - | 4.14 % | $ 49.1 M | USA |
 |
I-Mab
IMAB
|
1.72 B | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
715 M | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
3.36 M | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
6.72 M | - | -18.52 % | $ 27.3 M |  Britain |
 |
Applied Molecular Transport
AMTI
|
60.8 M | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
-17.1 M | - | - | $ 8.42 M | USA |
 |
Aptorum Group Limited
APM
|
23.1 M | $ 0.9 | -0.02 % | $ 6.62 M | China |
 |
Biophytis SA
BPTS
|
2.27 M | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
-16.2 M | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
733 M | $ 22.46 | 0.72 % | $ 3.72 B | USA |
 |
Aptinyx
APTX
|
38.3 M | - | -39.0 % | $ 4.57 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
-1.1 M | - | - | $ 7.46 M |  Israel |
 |
Brainstorm Cell Therapeutics
BCLI
|
-9.98 M | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
188 M | - | -4.8 % | $ 255 M | USA |
 |
AIkido Pharma
AIKI
|
69.4 M | - | 1.93 % | $ 17.4 M | USA |
 |
Cara Therapeutics
CARA
|
20.9 M | - | -3.03 % | $ 260 M | USA |
 |
CASI Pharmaceuticals
CASI
|
84.5 M | - | - | $ 35.4 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
35.5 M | $ 6.81 | -0.58 % | $ 195 M | USA |
 |
ChromaDex Corporation
CDXC
|
76.5 M | - | -0.88 % | $ 598 M | USA |
 |
Galectin Therapeutics
GALT
|
-128 M | $ 2.37 | -0.04 % | $ 151 M | USA |
 |
AgeX Therapeutics
AGE
|
-37 K | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
10.7 M | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
-24.2 M | - | 17.91 % | $ 11.1 M | USA |
 |
Greenwich LifeSciences
GLSI
|
2.53 M | $ 23.76 | -0.96 % | $ 309 M | USA |
 |
BioNTech SE
BNTX
|
1.37 B | $ 101.26 | -0.78 % | $ 27.2 B | Germany |
 |
Checkpoint Therapeutics
CKPT
|
-12.6 M | - | - | $ 169 M | USA |
 |
Avenue Therapeutics
ATXI
|
1.83 M | - | -52.27 % | $ 4.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
29.5 M | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
-33.7 M | $ 4.14 | 1.1 % | $ 443 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
189 M | $ 23.67 | 1.07 % | $ 3.01 B | USA |
 |
Heron Therapeutics
HRTX
|
14.3 M | $ 1.19 | 0.01 % | $ 198 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
178 M | $ 1.45 | 2.13 % | $ 386 M | Britain |
 |
Aptose Biosciences
APTO
|
-27.2 M | - | -45.71 % | $ 1.2 M |  Canada |
 |
AstraZeneca PLC
AZN
|
15.6 B | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
94.7 M | - | 1083.1 % | $ 745 M | USA |
 |
InflaRx N.V.
IFRX
|
77.9 M | $ 1.81 | 12.11 % | $ 152 M | Germany |
 |
Can-Fite BioPharma Ltd.
CANF
|
5.59 M | $ 2.98 | 2.05 % | $ 4.91 M | Israel |
 |
BeiGene, Ltd.
BGNE
|
4.36 B | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Inventiva S.A.
IVA
|
111 M | $ 5.14 | 0.19 % | $ 138 M | France |
 |
Akero Therapeutics
AKRO
|
750 M | - | - | $ 3.67 B | USA |
 |
bluebird bio
BLUE
|
195 M | - | - | $ 546 M | USA |